Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Cash from Investing Activities (2023 - 2025)

Historic Cash from Investing Activities for Upstream Bio (UPB) over the last 3 years, with Q3 2025 value amounting to $48.2 million.

  • Upstream Bio's Cash from Investing Activities rose 331987.22% to $48.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$110.5 million, marking a year-over-year decrease of 363.76%. This contributed to the annual value of -$59.5 million for FY2024, which is 2819.46% up from last year.
  • Latest data reveals that Upstream Bio reported Cash from Investing Activities of $48.2 million as of Q3 2025, which was up 331987.22% from $12.8 million recorded in Q2 2025.
  • Upstream Bio's 5-year Cash from Investing Activities high stood at $48.2 million for Q3 2025, and its period low was -$213.4 million during Q1 2025.
  • Its 3-year average for Cash from Investing Activities is -$27.1 million, with a median of $7.1 million in 2024.
  • Examining YoY changes over the last 5 years, Upstream Bio's Cash from Investing Activities showed a top increase of 331987.22% in 2025 and a maximum decrease of 164043.46% in 2025.
  • Upstream Bio's Cash from Investing Activities (Quarter) stood at -$5.2 million in 2023, then skyrocketed by 899.47% to $41.9 million in 2024, then increased by 14.98% to $48.2 million in 2025.
  • Its last three reported values are $48.2 million in Q3 2025, $12.8 million for Q2 2025, and -$213.4 million during Q1 2025.